Shardul Amarchand Mangaldas & Co has advised Netherlands-headquartered speciality ingredient solutions provider Barentz International on its acquisition of India-based Anshul Life Sciences, which was represented by AZB & Partners.
Financial terms of the deal were not disclosed, but media sources put it at 170 million euros ($188 million).
The acquisition establishes a life sciences distribution platform for Barentz in India, with expected strategic growth opportunities across the Asia Pacific region. Anshul Life Sciences is a speciality chemical distributor focused on the regulated pharmaceutical, food and nutraceutical, and personal care markets.
The SAM team was led by partners Roopal Kulsrestha, Neelam Pathak, and Meghna Nachappa, and included associates Aparna R, Sandra Anil Varkey, Pranav Bajaj, and Sidharth Chamarthy.
The AZB team included senior partner Vaidhyanadhan Iyer and partner Sneha Nagvekar, along with associates Deepti Narayanan, Priyasha Goyal, Jay Singhee, and Meghna Somani.
